You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IV childhood small noncleaved cell lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)

Not yet recruiting
  • NSCLC Stage IV
  • ALK Fusion Protein Expression
  • Peptide vaccine
  • (no location specified)
Jul 21, 2023

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Oct 25, 2023

Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)

Active, not recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial (Poziotinib

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +3 more
  • Poziotinib Hydrochloride
  • 1429757-68-5, HM781-36B, NOV-1201 Hydrochloride, NOV120101 Hydrochloride, Poziotinib HCl, POZIOTINIB HYDROCHLORIDE
  • (no location specified)
Jul 18, 2022

NSCLC Trial in Ostrava (primary tumour radiotherapy, stereotactic body radiotherapy, maintenance radiotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • primary tumour radiotherapy
  • +2 more
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Dec 6, 2022

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Los Angeles (Autologous

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
  • Pembrolizumab
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Sacramento (Anti-PD-L1 Monoclonal Antibody MPDL3280A,

Terminated
  • Recurrent Non-Small Cell Lung Carcinoma
  • Stage IV Non-Small Cell Lung Cancer
  • Anti-PD-L1 Monoclonal Antibody MPDL3280A
  • Stereotactic Body Radiation Therapy
  • Sacramento, California
    University of California Davis
Aug 2, 2022

Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,

Recruiting
  • Esophageal Carcinoma
  • +16 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2022

NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

Recruiting
  • NSCLC Stage IV
  • +2 more
  • Hefei, Anhui, China
  • +4 more
Apr 15, 2023

Non-small Cell Bronchopulmonary Carcinoma at Stage IV and Benefiting From First-line Treatment According to Current French

Not yet recruiting
  • Non-small Cell Bronchopulmonary Carcinoma at Stage IV and Benefiting From First-line Treatment According to Current French Recommendations
  • Test Leeds Food Preference Questionnaire (LFQP-France)
  • (no location specified)
Aug 9, 2022

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +12 more
  • Computed Tomography
  • Contrast Agent
  • New Brunswick, New Jersey
  • +1 more
Nov 2, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Scottsdale, Arizona
  • +2 more
Jan 5, 2023

EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

Recruiting
  • EGFR Exon 20 Mutation
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Aspirin in Combination With Trametinib and Dabrafenib

Not yet recruiting
  • NSCLC
  • +4 more
  • Combind asprin with Trametinib and Dabrafenib
  • (no location specified)
Aug 4, 2023

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial in Rochester (Best Practice,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Best Practice
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 14, 2023

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

Recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

NSCLC Trial in Worldwide (BMS-986315, Nivolumab, Pemetrexed)

Not yet recruiting
  • NSCLC
  • Boise, Idaho
  • +12 more
Oct 17, 2023

Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Non Small Cell Lung Cancer Trial in Ostrava (Chemotherapy, Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT),

Recruiting
  • Non Small Cell Lung Cancer
  • Chemotherapy
  • +2 more
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Dec 19, 2022

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +2 more
  • Birmingham, Alabama
  • +10 more
Jan 25, 2023

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Trial in United States

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +5 more
  • San Francisco, California
  • +3 more
Aug 17, 2022

Blood Samples in Patients With Non-small Cell Lung Cancer

Recruiting
  • Stage III Non-Small Cell Lung Cancer AJCC v7
  • +3 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 18, 2022

NSCLC Stage IV Trial in New York (Pembrolizumab, Radiation, Chemotherapy)

Recruiting
  • NSCLC Stage IV
  • New York, New York
    NYU Langone Health
Jan 11, 2023

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023